预印本开放获取
Programable Albumin-Hitchhiking Nanobodies Enhance the Delivery of STING Agonists to Potentiate Cancer Immunotherapy
John T. Wilson, Blaise R. Kimmel, Karan Arora, Neil C. Chada, Vijaya Bharti, Alexander J. Kwiatkowski, Jonah Finklestein, Ann Hanna 等 25 位
Vanderbilt University John Wiley & Sons (United States) Vanderbilt University Medical Center
阅读操作
确认中在文库中上传 PDF 后可生成中文音频讲解。
摘要与影响
摘要 · 节选
暂未获取摘要。可打开原文或 PDF，后续可基于全文生成更完整的速读。
逐年被引趋势
420
425
关键指标
4
被引次数 · OpenAlex
-
领域内被引倍数
同类平均 = 1
同类平均 = 1
-
引用位次
同领域 · 同年份 · 同类型
同领域 · 同年份 · 同类型
82
参考文献
Google Scholar 与 OpenAlex 的被引统计范围不同，数值存在差异属正常。
AI 辅助阅读
依据：文献信息
论文问答
当前基于文献信息回答
可就本文提问；依据不足时会说明。
学术脉络
学科主题
生物医学interferon and immune responses
Cancer Research and Treatments · Virus-based gene therapy research
参考文献 82
Practical Considerations for the Pharmacokinetic and Immunogenic Assessment of Antibody–Drug Conjugates
被引 21Melody Sauerborn, William Van Dongen · BioDrugs · 2014
Oncology Meets Immunology: The Cancer-Immunity Cycle
被引 7,063Daniel S. Chen, Ira Mellman · Immunity · 2013
STING is a direct innate immune sensor of cyclic di-GMP
被引 1,577Dara Burdette, Kathryn M. Monroe, Katia Troha · Nature · 2011
此处列出前 3 条
引用本文 4
Dynamic Size‐Change Nanovaccine for Enhancing Lymph Node Deep Penetration and Eliciting Robust Antitumor Immune Responses
被引 14Liping Liu, Zichao Huang, Zhenyi Zhu · Advanced Materials · 2025
Research trends in the use of nanobodies for cancer therapy
被引 12Jun Hou, Kun Du, Jinling Li · Journal of Controlled Release · 2025
From antibodies to nanobodies: The next frontier in cancer theranostics for solid tumors
被引 1Sanjana Mehrotra, Navdeep Kaur, Sukhpreet Kaur · Advances in protein chemistry and structural biology · 2025
按被引量排序，此处列出前 3 条